ATLANTA--(BUSINESS WIRE)--AMNIOX Medical, Inc., a TissueTech, Inc. company, announced that Palmetto Medicare recently released its new Skin Substitute medical policy, effective May 17, 2016, covering NEOX® CORD 1K and NEOX® 100 wound allografts. The 3.6 million additional lives covered by Palmetto Medicare contribute to the more than 27.6 million lives with access to Amniox products, or more than 70 percent of lives covered by Medicare nationwide. The policy change allows for skin substitute ap
↧